Salarius Pharmaceuticals Inc (SLRX)

Salarius Pharmaceuticals (SLRX) Financial Statements


Salarius Pharmaceuticals Financial Overview

Salarius Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.538; its P/E ratio is -0.11; Salarius Pharmaceuticals is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -881.80K$ -2.44M$ -3.88M$ -5.42M$ -6.48M
EBITDA$ -880.69K$ -2.44M$ -3.88M$ -5.42M$ -6.47M
Net Income Common Stockholders$ -881.80K$ -2.44M$ -3.88M$ -5.34M$ -6.37M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.90M$ 7.58M$ 11.54M$ 9.27M$ 12.11M
Total Assets$ 6.59M$ 8.40M$ 12.03M$ 10.06M$ 14.65M
Total Debt$ 300.00K$ 500.00K$ 0.00$ 0.00$ 0.00
Net Debt$ -5.60M$ -7.08M$ -11.54M$ -9.27M$ -12.11M
Total Liabilities$ 1.30M$ 2.32M$ 3.64M$ 4.50M$ 4.27M
Stockholders Equity$ 5.29M$ 6.08M$ 8.41M$ 5.56M$ 10.38M
Cash Flow-
Free Cash Flow$ -1.51M$ -3.75M$ -4.42M$ -3.15M$ -4.71M
Operating Cash Flow$ -1.51M$ -3.75M$ -4.42M$ -3.15M$ -4.71M
Investing Cash Flow-----
Financing Cash Flow$ -169.45K$ -211.83K$ 6.68M$ 336.68K$ 1.00
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

Salarius Pharmaceuticals Debt to Assets

Salarius Pharmaceuticals Cash Flow

Salarius Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis